Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Chemistry World March 20, 2008 Richard Van Noorden	UK Drug Firms to Slash Research and Jobs The UK pharmaceutical industry is expecting to cut jobs and investment in R&D following an alarming slump in confidence in the UK market.
Chemistry World February 2, 2012 Andrew Turley	AstraZeneca to cut 7300 more jobs UK drugmaker AstraZeneca has announced plans to cut a further 7300 jobs to make annual savings of $1.6 billion by the end of 2014, a move that will cost the company $2.1 billion in the near term.
Chemistry World January 30, 2014 Phillip Broadwith	AstraZeneca ends R&D in India Pharmaceutical firm AstraZeneca is quitting its R&D site in Bangalore, India.
IndustryWeek July 22, 2009 Jonathan Katz	America's View of Manufacturing: By the Numbers Deloitte's 'Public Viewpoint on Manufacturing' study highlights manufacturing's importance in the U.S. economy.
Chemistry World April 16, 2010 Sean Milmo	Ineos starts UK chemicals exodus Ineos's decision to relocate its headquarters to Switzerland because of corporate taxation concerns may spark an exodus of chemical and pharmaceutical companies from having their headquarters in the UK.
Chemistry World June 11, 2008 James Mitchell Crow	GSK Job Cuts Hit Chemists GlaxoSmithKline is cutting the jobs of hundreds of scientists as it restructures its drug R&D operations.
Chemistry World February 2, 2007 Victoria Gill	AstraZeneca Follows Pfizer in Slashing Workforce The Anglo-Swedish pharmaceutical hopes that by streamlining its operation it can offset the growing financial threat from cheap generic copies of its best-selling blood pressure drug. Nevertheless, the company has reported unexpectedly cheerful fourth quarter profits.
Chemistry World March 2011 Bea Perks	Editorial: At the forefront The news that most of Pfizer's 2400 employees at Sandwich, U.K. will be made redundant over the next two years was met with surprise, disappointment and anger.
Chemistry World February 2, 2011 Andy Extance	Pfizer to close historic UK site Most of the 2400 people employed at the Pfizer site in Sandwich, UK, will be made redundant over the next 18-24 months as the US pharma giant restructures its research operations.
IndustryWeek June 1, 2006 Patricia Panchak	Editor's Page -- U.S. Manufacturing's Global Future Here's what we can learn from big energy's strong showing.
Pharmaceutical Executive September 1, 2008	How Do You Solve a Problem Like Manufacturing? Outsourcing saves pharmaceutical companies money -- except when it doesn't. Here's how to decide what to do.
Chemistry World May 28, 2014 Phillip Broadwith	Time called on Pfizer -- AstraZeneca deal Pfizer's pursuit of a pharmaceutical megamerger has concluded with the US giant withdrawing its final offer two hours before the deadline set by the UK's takeover rules.
Chemistry World January 28, 2010 Nina Notman	AstraZeneca's workforce slashed again Pharma giant AstraZeneca is to cut another 8,000 jobs globally over the next four years - with approximately 1,800 additional research and development staff to be lost.
The Motley Fool October 11, 2011 Cliff D'Arcy	AstraZeneca Loves This $100Bn Market The British pharma firm makes its largest-ever manufacturing investment -- in China.
Chemistry World April 29, 2014 Phillip Broadwith	Pfizer courts AstraZeneca megamerger US-based pharma behemoth Pfizer has publically announced its intention to make a merger offer to the UK's AstraZeneca, in a deal valued at around $100 billion.
Chemistry World March 19, 2013 Simon Hadlington	Global AstraZeneca restructuring will cost 1600 jobs The company's global research blueprint will now be centered on the creation of three 'strategic R&D centers' for small molecules and biologics, to be based in Cambridge in the UK, Gaithersburg in Maryland, US, and Molndal in Sweden, to be completed by 2016.
The Motley Fool January 5, 2010 Brian Orelli	A Deal Manufactured by Necessity Genzyme gets some help from a new friend.
Chemistry World August 3, 2012 Andrew Turley	Pfizer secures Sandwich buyer Pfizer has found a buyer for its R&D site in Sandwich, UK: the site -- now called Discovery Park -- has been bought by a private consortium, according to Kent County Council.
The Motley Fool February 25, 2011 Brian Orelli	Minor Delay, Major Missed Opportunity Protalix and Pfizer's Gaucher disease drug gets delayed.
Chemistry World March 8, 2011 Andy Extance	GSK will pay off UK graduate tuition fees Potential undergraduate chemistry students concerned about their prospects in the face of plant closures and increased tuition fees have been given some cheer by pharmaceutical giant GlaxoSmithKline.
IndustryWeek March 1, 2008 David Blanchard	Just In Time -- Buddy, Can You Spare a Job? U.S. manufacturers assert their continuing relevance despite a decline in overall employment and a lack of commitment from politicians.
The Motley Fool October 14, 2010 Sean Williams	Should You Let AstraZeneca Go? Multiple drug patent expirations await. It's time to run away.
BusinessWeek June 2, 2011 Kresge & Connolly	A New Pricing Game for Drugmakers in Europe Germany's new rules tying pharmaceutical prices to greater efficacy is worrying companies.
Chemistry World July 9, 2008 James Mitchell Crow	Pharma goes green to cut costs The pharmaceutical industry's current drive to curb spending is helping to speed the adoption of green chemistry, say experts in the industry.
The Motley Fool September 15, 2010 Brian Orelli	Drug Approved. Now Let's Sell This Baby! With ink still wet on its FDA approval, Savient continues its plan to find a buyer.
IndustryWeek December 1, 2008 Jill Jusko	Focus on the Process Industries: Pharmaceuticals: Reworking the Pharma Supply Chain As multiple forces challenge the pharmaceutical industry, supply chains get a new look.
IndustryWeek December 14, 2011 Pat Panchak	What if Public Policy Changes Are Not Enough? An important question - and its answer - reveal potential shortcomings in our approach to strengthening U.S. manufacturing.
IndustryWeek January 1, 2007	Different Priorities Depending on your industry, there are significant differences in investment prioritization for manufacturing operations software.
Chemistry World September 7, 2011 Andrew Turley	First Pfizer Spinout at Sandwich Green shoots of recovery are starting to sprout at the Pfizer site in Sandwich, UK, with the first spinout opening its doors.
IndustryWeek November 16, 2011 Patricia Panchak	Manufacturing Moves to Center Stage Public-policy leaders are taking yet another look at manufacturing's importance to the U.S. economy. This time, let's make sure they get it right.
IndustryWeek February 17, 2010	First Up -- The Case for Investing in Manufacturing Our ability to field competitive domestic manufacturing industries is deteriorating, says one economist, and too few understand the implications for the U.S. economy.
National Defense February 2004 Lawrence P. Farrell Jr.	State of Manufacturing Base Is Cause for Concern One lesson that we learned from the "Buy America" debate last year was the need for a thorough and detailed discussion on a national level about the state of the U.S. industrial base, particularly the capabilities of American industry to manufacture sophisticated components for weapon systems.
IndustryWeek March 1, 2005 Michael K. Evans	Evans On The Economy -- More Jobs Will Be Lost What will happen to the U.S. economy as manufacturing employment continues to shrink? Manufacturing workers will be hurt, but not the U.S. economy generally.
IndustryWeek January 20, 2010 Wade Harter	Letters to the Editor For February 2010 Manufacturing has to help itself to become leaner and meaner.
IndustryWeek March 1, 2008 Jill Jusko	IW Best Plants Program: In Search of Excellence Nominations are now open for an annual salute to outstanding manufacturing facilities in North America.
IndustryWeek June 22, 2011	Ryan: Lead the World in Advanced Manufacturing One of the simplest things government could do to help U.S. manufacturing is encourage the Pentagon to spend more of its $500 billion budget on domestically produced products.
The Motley Fool November 12, 2009 Brian Orelli	How Do You Say 'Drug Development' in Mandarin? Drug giant Novartis announces that it's heading to China in a big way.
Chemistry World October 23, 2008 Matt Wilkinson	Merck to slash more jobs Beleaguered US pharma giant, Merck & Co., has announced new restructuring plans that will see the company cut 7,200 jobs in an effort to save up to $4.2 billion
IndustryWeek June 1, 2005	Letters To The Editor For June 2005 'Kudos all around' for the April 2005 issue... "More Jobs Will Be Lost" misses the boat on manufacturing...
Chemistry World August 17, 2012 Andrew Turley	Pfizer to pay $250m for Nexium Pfizer has struck a $250 million deal with UK rival AstraZeneca to sell an over-the-counter version of Nexium (esomeprazole magnesium) heartburn tablets.
The Motley Fool December 27, 2007 Brian Orelli	Drugmaker Growth: The China Connection Just like other industries, the pharmaceutical industry has realized that China is a good place to find cheap labor. While reluctant to set up FDA-regulated manufacturing plants in China, other stages of drug development can be done there.
Chemistry World March 22, 2012 Andrew Turley	GSK to build 350 million factory in UK GlaxoSmithKline has announced plans to build its first new UK production plant for almost 40 years in Ulverston, Cumbria.
Chemistry World April 24, 2007 Victoria Gill	AstraZeneca Scoops up $15.6 Billion Vaccine Business AstraZeneca has joined the race to scoop up acquisition opportunities in the biologics sector with a $15.6 billion deal to buy U.S. vaccines and biotechnology company MedImmune.
National Defense January 2007 Lawrence P. Farrell Jr.	Manufacturing Edge Essential to Defense While the U.S. defense industry remains unsurpassed, it faces long-term challenges - one of which is its ability to secure innovative manufacturing capabilities. This applies all the way from bombers to boots.
Inc. September 1, 2009	My Story: J. Larry Sanders of SFP The author describes his business of manufacturing an additive for fertilizers to increase crop yields and help the environment.
IndustryWeek September 22, 2010	Is This Good For Manufacturing? Manufacturing czar Ron Bloom believes that his only role in the Obama administration is to ask the question, or force the question: Is this good for manufacturing?
IndustryWeek May 20, 2009	First Up -- Sweating the Big Stuff -- and It's All Big Stuff It's time to put manufacturing on the list of national issues we must address now.
IndustryWeek November 1, 2006 John S. McClenahen	Employment: Texas Dominates The Southwest's Top 10 Houston tops out list with 222,477 manufacturing jobs.
IndustryWeek September 16, 2009 Ralph Keller	Continuous Improvement -- What's the Future of U.S. Manufacturing? Some claim manufacturing is dying here but the numbers tell a different story.
IndustryWeek August 1, 2003 John Teresko	Fearing R&D's Flight Research and development is an increasingly crucial factor in sustaining the competitiveness of U.S. manufacturing amid rapid globalization. Yet experts warn that strategic missteps endanger U.S. technological preeminence.